Here’s a discussion on whether it’s reasonable to be pessimistic about digital-health and related products.

One discussant, venture capitalist Lisa Suennen, told MedCity News that there’s been “a lot of optimism about the convergence of biotech, life sciences and health IT, but also there was a sense of foreboding that the party is over in some of these areas.

MedCity’s Stephanie Baum, for her part, predicted:

“It’s definitely going to be a quiet year for IPOs in digital health. I think people are going to be buckling down and getting ready for 2017. In 2015 we had Teladoc and Fitbit, but this year, there may be one or two, but it’s definitely going to be quiet on that front.”